Archive · 25 Jul 2025
Experts Advocate Early Hepatitis B Treatment to Save Lives
Hepatitis B is a serious illness that can lead to liver problems and even death.
Doctors have medicines to treat it, but not enough people are getting them.
These medicines work well and are not too expensive.
Starting treatment early helps stop the disease from getting worse, like slowing down damage to the liver.
When mothers have hepatitis B, they can pass it to their babies, causing them to be infected too.
Using the medicines more often can help save many lives and reduce cases of liver cancer.
Hepatitis B drugs are vastly underused despite being safe and effective.
Early treatment with these drugs can slow disease progression and prevent liver damage.
Less than 3% of HBV-infected individuals receive treatment.
HBV causes significant emotional, mental, and social burdens.
Early treatment could significantly reduce liver cancer incidence and save millions of lives.
- Who
- Scientists and researchers, including John Tavis, are advocating for increased hepatitis B treatment.
- What
- Hepatitis B drugs are being underused, impacting treatment efficacy.
- When
- The study's findings were published in Lancet Gastroenterology and Hepatology.
- Where
- The article mentions research and commentary related to Hepatitis B treatment.
- Why
- To save lives and reduce the incidence of liver cancer and liver failure.
Current Treatment Approach
Advocates' Stance
Treatment Timing
Current Treatment Approach
Many people infected with Hepatitis B are not receiving treatment early.
Advocates' Stance
Early treatment is crucial to slowing down the disease and prevent liver damage.
- Daily Deaths from HBV
- Over 3,000
- People dying without treatment
- 20-40%
- Treatment Rate
- Less than 3% of infected people
- Main mode of transmission
- Mother to infant
- Impact on Cancer
- Drugs could reduce liver cancer by two-thirds or three-quarters